Ozempic (semaglutide) Disease area(s): Metabolic diseases Manufacturer(s): Novo Nordisk 2024 Sales (USD): $17.45 billion Why it sold so well: Novo Nordisks GLP-1 blockbuster for type 2 diabetes continued its impressive growth in 2024, with sales increasing by 26% year-over-year to DKK 120.3 billion ($17.45 billion)
Everything you need to knowcheck out the CircadiYin review
We injected different concentrations of insulin into the mixing module through the sample inlet and injected a solution of fluorescently tagged dAbs and microbeads functionalized with the insulin cAb through the reagent inlet
Nature 633 , 895904 (2024)
When it becomes inflamed, the body signals distress, and if left untreated, the appendix can rupture, leading to more severe complications
If nausea worsens, discontinue and consult your PlexusDx clinician